Sexual Wellness After Menopause: Symptoms, Evaluation, and Treatment Options

For Her

Oct 2

Menopause can affect sexual health in ways that are physical, emotional, and deeply personal. Some women notice vaginal dryness, discomfort during sexual activity, changes in desire, reduced arousal, or urinary symptoms. Others experience few or no sexual-health changes.

These concerns are common, but they should not be dismissed or reduced to “just getting older.” They also should not be treated with the assumption that every woman needs hormone therapy or a regenerative procedure.

At OTR Health & Wellness in Cumming, Georgia, women can discuss menopausal and sexual-health concerns in a private clinical setting. A licensed healthcare professional can review possible causes, determine whether an examination or referral is appropriate, and discuss established and emerging options with realistic expectations.

Understanding Genitourinary Syndrome of Menopause

The term genitourinary syndrome of menopause, or GSM, describes a group of changes that may occur as estrogen and other sex-hormone levels decline. GSM can affect the vulva, vagina, urethra, bladder, and sexual function.

Possible symptoms include:

Vaginal or vulvar dryness
Burning, irritation, or itching
Discomfort or pain with penetration
Spotting or bleeding related to fragile tissue
Reduced lubrication during sexual activity
Urinary urgency, frequency, or burning
Recurrent urinary tract infections
Changes in arousal, sensation, or sexual comfort

Unlike hot flashes, which may improve over time, GSM symptoms may continue or worsen without appropriate management. However, symptoms such as pain, itching, bleeding, discharge, odor, or urinary discomfort are not always caused by menopause.

Infections, dermatologic conditions, pelvic-floor dysfunction, medication effects, vulvodynia, bladder disorders, and other gynecologic conditions can produce similar symptoms. An evaluation is important before assuming that estrogen loss is the only cause.

Sexual Desire Is More Than One Hormone

Sexual desire can change after menopause, but low desire does not automatically mean that estrogen, progesterone, or testosterone is “out of balance.” Desire is influenced by many factors, including:

Pain or fear of pain
Sleep disruption and fatigue
Relationship concerns
Stress, anxiety, or depression
Body image
Medical conditions
Prescription medications
Previous sexual experiences or trauma
Changes in arousal or orgasm
Menopausal symptoms

Treating vaginal discomfort may improve a woman’s ability to participate in sexual activity, but it does not guarantee increased desire, arousal, orgasm, confidence, or relationship satisfaction.

A useful evaluation considers the symptom that is most concerning to the patient rather than assuming that one procedure can address every aspect of sexual wellness.

Start With a Thoughtful Evaluation

A sexual-health evaluation may include:

When symptoms began and how they affect daily life or intimacy
Menstrual and menopause history
Vaginal, vulvar, urinary, and pelvic symptoms
Medical and surgical history
Prescription medications and supplements
Personal or family history of hormone-sensitive cancer
Relationship, mood, stress, and sleep considerations
Sexual goals and treatment preferences
A pelvic examination or laboratory testing when indicated
Referral to a gynecologist, urologist, pelvic-floor physical therapist, dermatologist, sex therapist, or another qualified professional when appropriate

Not every patient needs laboratory testing. GSM is generally evaluated from the symptoms and clinical findings rather than diagnosed through a broad hormone panel.

Postmenopausal bleeding should be evaluated by an appropriate healthcare professional. Women should also seek care for persistent pelvic pain, a new lesion or lump, unusual discharge or odor, unexplained bleeding, or symptoms of a urinary infection.

Lubricants and Vaginal Moisturizers

For some women, nonprescription products are a reasonable first step.

Lubricants are used during sexual activity to reduce friction and discomfort. Water- and silicone-based products are common choices. Ingredients that cause burning, cooling, warming, or irritation may be uncomfortable for sensitive tissue.

Vaginal moisturizers are used on a regular schedule rather than only during sexual activity. They are intended to help maintain moisture and reduce everyday dryness or irritation.

These products do not reverse menopause or correct a hormone deficiency, but they may provide meaningful symptom relief. The most appropriate product depends on the patient’s symptoms, sensitivities, sexual practices, and use of condoms or other devices.

Prescription Options for GSM

When nonprescription measures are not sufficient, a licensed healthcare professional may discuss prescription treatment. Options may include:

Low-Dose Vaginal Estrogen

Low-dose vaginal estrogen is available in forms such as creams, tablets, inserts, or rings. It may be considered for vaginal dryness, irritation, and pain associated with GSM.

The decision should account for the patient’s symptoms, medical history, preferences, contraindications, and other medications. Women with a history of breast cancer or another hormone-sensitive condition should discuss treatment with the clinicians involved in their cancer and gynecologic care.

Vaginal Prasterone

Prasterone, also called vaginal DHEA, is an FDA-approved prescription option for certain women with moderate to severe pain during sexual activity related to menopause. Potential benefits, risks, contraindications, and proper use should be reviewed with a healthcare professional.

Ospemifene

Ospemifene is an oral selective estrogen-receptor modulator approved for certain moderate to severe GSM symptoms. Because it acts throughout the body rather than only at the vaginal tissue, an individualized assessment of risks, medication interactions, and contraindications is important.

Systemic Menopausal Hormone Therapy

Systemic hormone therapy may be considered for some women with bothersome hot flashes, night sweats, or other menopausal symptoms, but it is not appropriate for everyone. If vaginal symptoms are the only concern, a local treatment may be considered instead.

Patients should receive an individualized discussion of benefits, risks, alternatives, treatment duration, and available FDA-approved options. Compounded hormone preparations are not FDA-approved and should not be described as safer or more effective simply because they are called “bioidentical.”

Pelvic-Floor and Sexual-Health Support

Pain with sexual activity is not always caused by dryness alone. Pelvic-floor muscles may tighten in anticipation of pain, which can make penetration increasingly difficult or uncomfortable.

Depending on the evaluation, nonprocedural support may include:

Pelvic-floor physical therapy
Gradual vaginal dilator therapy under professional guidance
Modification of sexual activities or positions
Counseling with a qualified sex therapist
Individual or couples counseling
Treatment of anxiety, depression, pain, or sleep concerns

These approaches may be used alone or alongside medical treatment. Referral does not mean symptoms are “all in the mind.” Sexual pain and changes in desire often have interacting physical, emotional, and relational components.

What Is the O-Shot®?

The O-Shot® is a branded procedure in which platelet-rich plasma, or PRP, prepared from a patient’s own blood is injected into genital tissue. It has been promoted for concerns such as sexual dysfunction, reduced sensation, difficulty with orgasm, urinary leakage, and GSM.

PRP contains platelets and growth factors involved in normal healing, but that biological description does not establish that an injection will regenerate vaginal tissue, restore nerves, create new blood vessels, improve orgasm, or correct the underlying cause of a patient’s symptoms.

Research on PRP for menopausal genital and sexual-health concerns remains limited. Existing studies have varied in their design, preparation methods, injection techniques, outcome measures, and follow-up. Larger, well-designed randomized trials are needed to establish effectiveness, durability, appropriate patient selection, and long-term safety.

PRP is not FDA-approved specifically to treat GSM, female sexual dysfunction, orgasm difficulties, urinary incontinence, or menopausal vaginal symptoms. Preparing PRP from a patient’s own blood does not make the procedure risk-free.

Potential risks may include:

Pain, bleeding, bruising, or swelling
Infection
Tissue or nerve injury
Temporary or persistent changes in sensation
Lack of improvement or worsening symptoms
The need for additional care

Patients considering an O-Shot® or another genital PRP procedure should be told that results are uncertain and not guaranteed. A consultation should clarify the intended indication, available evidence, alternatives, expected costs, provider training, aftercare, and what will happen if symptoms do not improve.

What About Acoustic Wave or Other Energy-Based Procedures?

The phrase “acoustic wave therapy” may refer to different devices and technologies. Other procedures promoted for vaginal or sexual wellness may use laser, radiofrequency, ultrasound, or different forms of energy. These technologies are not interchangeable, and evidence from one device or procedure should not be used to support claims about another.

Marketing language may state that a procedure increases circulation, forms new blood vessels, produces collagen, restores lubrication, repairs tissue, or improves sexual responsiveness. These biological and clinical claims require reliable evidence for the exact device, treatment protocol, and medical indication.

Patients should ask:

What is the exact device and technology being used?
Is the device FDA-cleared or approved for this specific indication?
What published evidence supports its use for my condition?
Is the treatment considered investigational or off-label?
What are the potential risks and alternatives?
How many treatments are recommended, and what is the total cost?
What follow-up is provided if symptoms persist or worsen?

FDA clearance of a device for one purpose does not establish approval for vaginal rejuvenation, sexual dysfunction, GSM, urinary incontinence, or another unlisted use. Patients should not be promised new blood-vessel formation, restored sensitivity, improved lubrication, stronger orgasms, tissue regeneration, or lasting sexual satisfaction.

Possible procedural risks vary by device and treatment area. They may include pain, bleeding, burns, scarring, infection, altered sensation, discomfort during sexual activity, and lack of benefit. The exact risks should be reviewed before consent.

Urinary Symptoms Need the Right Diagnosis

Urinary leakage, urgency, frequency, burning, and recurrent infections may occur around and after menopause, but they do not all have the same cause.

Stress urinary incontinence involves leakage during coughing, laughing, lifting, or exercise. Urgency incontinence involves a sudden compelling need to urinate that may be followed by leakage. Burning or frequency may be caused by a urinary infection, GSM, bladder irritation, or another condition.

An O-Shot® or acoustic procedure should not be presented as a proven treatment for all urinary symptoms. Depending on the diagnosis, established options may include pelvic-floor therapy, bladder training, medication, treatment of GSM, pessary use, or referral for urologic or urogynecologic care.

Setting Realistic Expectations

Sexual wellness is not measured by one laboratory value or one procedural outcome. A treatment may improve a specific physical symptom without changing desire, orgasm, body image, confidence, or relationship dynamics.

Patients deserve clear information about:

The condition being treated
Whether a treatment is FDA-approved for that indication
The strength and limitations of the evidence
Possible benefits and risks
Established alternatives
Costs and the likely number of visits
Follow-up and monitoring
The possibility of no improvement

No therapy or procedure can guarantee increased desire, painless intercourse, stronger orgasms, improved confidence, restored intimacy, urinary control, or a particular quality-of-life result.

Women’s Sexual-Health Consultations in Cumming, GA

OTR Health & Wellness serves patients in Cumming and surrounding North Georgia communities, including Forsyth County, Alpharetta, Johns Creek, Suwanee, Dawsonville, Buford, Canton, and Gainesville.

If vaginal dryness, discomfort, pain during sexual activity, changes in desire, or urinary symptoms are affecting your quality of life, a consultation can provide a starting point. A licensed healthcare professional can review possible causes, discuss established options, explain the limitations of emerging procedures, and recommend referral when another type of care is appropriate.

Menopause does not mean that sexual-health concerns should be ignored. It does mean that treatment choices should be individualized, evidence-informed, and based on clear consent rather than promises of regeneration or guaranteed results.

Medical Disclaimer

This article is for general educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Reading this content, contacting OTR Health & Wellness, or submitting a form does not create a provider-patient relationship. Treatment recommendations are made only after an appropriate evaluation by a licensed healthcare professional. No treatment, prescription, procedure, or result is guaranteed. Individual eligibility and outcomes vary. OTR Health & Wellness does not provide emergency medical care. If you are experiencing a medical emergency, call 911 or seek immediate emergency assistance.